Evermay Wealth Management LLC Abb Vie Inc. Transaction History

Evermay Wealth Management LLC

$661 Million
Q1 2024

A detailed history of Evermay Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Evermay Wealth Management LLC holds 7,584 shares of ABBV stock, worth $1.26 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,584

Previous 7,466 1.58%

Holding current value

$1.26 Million

Previous $1.16 Million 19.36%

% of portfolio

0.21%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $18,858 - $21,487	118 Added 1.58%	7,584 $1.38 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $16,649 - $18,751	-121 Reduced 1.59%	7,466 $1.16 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $7,748 - $8,969	58 Added 0.77%	7,587 $1.13 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $86,131 - $107,185	-650 Reduced 7.95%	7,529 $1.01 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $58,567 - $67,448	-405 Reduced 4.72%	8,179 $1.3 Million

Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $88,518 - $106,156	-640 Reduced 6.94%	8,584 $0
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $37,444 - $42,946	-279 Reduced 2.94%	9,224 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $28,212 - $35,866	205 Added 2.2%	9,503 $1.46 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $40,781 - $50,598	309 Added 3.44%	9,298 $1.51 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $26,857 - $33,982	250 Added 2.86%	8,989 $1.22 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $28,196 - $32,006	265 Added 3.13%	8,739 $943,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $31,508 - $34,686	-308 Reduced 3.51%	8,474 $917,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $27,366 - $36,947	-340 Reduced 3.73%	8,782 $941,000
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $8,591 - $10,083	100 Added 1.11%	9,122 $799,000
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $39,252 - $52,526	-535 Reduced 5.6%	9,022 $886,000
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $43,279 - $65,617	-671 Reduced 6.56%	9,557 $728,000
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $64,051 - $80,142	-888 Reduced 7.99%	10,228 $906,000
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $109,459 - $131,601	-1,738 Reduced 13.52%	11,116 $842,000
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $70,364 - $89,942	-1,071 Reduced 7.69%	12,854 $935,000
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $64,411 - $75,809	-835 Reduced 5.66%	13,925 $1.12 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $9,964 - $12,289	-128 Reduced 0.86%	14,760 $1.36 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $106,869 - $118,805	-1,202 Reduced 7.47%	14,888 $1.41 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $377,148 - $505,037	4,099 Added 34.18%	16,090 $1.52 Million
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $353,314 - $387,438	3,945 Added 49.03%	11,991 $1.16 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $562,013 - $717,864	8,046	8,046 $715,000

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.

Account

Evermay Wealth Management LLC Abb Vie Inc. Transaction History